Sign Up to like & get
recommendations!
2
Published in 2023 at "Pharmaceuticals"
DOI: 10.3390/ph16020207
Abstract: The aim of the present study is to develop Doxorubicin–Erlotinib nanoparticles (Dox–Erlo NPs) and folate-armored Dox–Erlo-NP conjugates for targeting glioma cancer. Glioma is one of the most common progressive cancerous growths originating from brain glial…
read more here.
Keywords:
erlo nps;
erlo conjugates;
erlo;
dox erlo ... See more keywords